IPO11 Is Upregulated in Relapsed AML and Supports Survival of Leukemic Stem Cells

Patients with relapsed AML (Acute Myeloid Leukemia) have a poor prognosis and few therapeutic options. Therefore, it remains critical to identify biological vulnerabilities in relapsed AML cells. To identify such vulnerabilities, we analyzed mRNA expression by RNA sequencing of 11 paired diagnosis a...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Blood 2019-11, Vol.134 (Supplement_1), p.2530-2530
Hauptverfasser:	Nachmias, Boaz, Voisin, Veronique, Hurren, Rose, Wang, Xioaming, Maclean, Neil, Xu, G. Wei, Seneviratne, Ayesh K, Xu, Changjiang, Bader, Gary D, Shlush, Liran I., Schimmer, Aaron D
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!